Edoxaban tosylate
-
Edoxaban tosylate
structure -
-
CAS No:
480449-71-6
-
Formula:
C24H30ClN7O4S.C7H8O3S
-
Chemical Name:
Edoxaban tosylate
-
Synonyms:
Ethanediamide,N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-,4-methylbenzenesulfonate (1:1);Ethanediamide,N-(5-chloro-2-pyridinyl)-N′-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-,mono(4-methylbenzenesulfonate);Edoxaban tosylate;DU 176b;Savaysa;Lixiana;Roteas;912273-65-5
- Categories:
-
CAS No:
Description
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:Target: factor XaEdoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses[1].in vitro: Edoxaban PK was not affected by concomitant low-dose ASA or naproxen, but high-dose ASA incr
Edoxaban tosylate is an organosulfonate salt obtained by combining equimolar amounts of edoxaban and 4-toluenesulfonic acid. Used (in the form of its monohydrate) for the treatment of deep vein thrombosis and pulmonary embolism. It has a role as an anticoagulant, an EC 3.4.21.6 (coagulation factor Xa) inhibitor and a platelet aggregation inhibitor. It contains an edoxaban(1+).|Edoxaban Tosylate is the tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.
Edoxaban tosylate Basic Attributes
720.25912
719.196289
1592732-453-0
32W99UE810
DTXSID10197399
C96542
B01|B01AF03
Safety Information
|Warning|H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]|P260, P264, P270, P301+P312, P314, P330, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA)., , Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.,|Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.|Prevention of arterial thromboembolism, Prevention of venous thromboembolism, Treatment of venous thromboembolism
Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)
DU-176
Edoxaban tosylate Use and Manufacturing
Human drugs -> Lixiana -> EMA Drug Category|Antithrombotic agents -> Human pharmacotherapeutic group|Human drugs -> Roteas -> EMA Drug Category|Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:720.3
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:6
Exact Mass:719.1962666
Monoisotopic Mass:719.1962666
Topological Polar Surface Area:228
Heavy Atom Count:48
Complexity:1090
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Edoxaban tosylate
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Active Pharm Ingredients,Chemical Catalyst,Pharmaceutical Intermediates,Flavors and Fragrances,Agrochemicals,Chemical Pesticides,Organic Intermediates,OLED IntermediatesInquiryCAS No.: 480449-71-6Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 480449-71-6Grade: Pharmaceutical GradeContent: 99.5% -
CN
3 YRS
Business licensed Certified factoryManufactory Supplier of Dyes,Textile agent,Medical intermediate,API,Pigments,Basic Chemicals -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Fimasartan and intermediates,Ticagrelor and intermediates,Oseltamivir Phosphate and intermediates,Edoxaban (tosylate),Fluvoxamine maleate and intermediates,Orlistat and Intermediates,Edoxaban (tosylate Monohydrate),Fumarate vonorazan and intermediates,Ilaprazole and intermediates,Carbinoxamine Maleate Salt,Doxylamine succinate,Vonoprazan FuMarate and its intermediate,Edoxaban and intermediates,ZonisamideInquiryCAS No.: 480449-71-6Grade: Pharmaceutical GradeContent: 99% -
CN
2 YRS
Business licensedTrader Supplier of Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib
Learn More Other Chemicals
-
10-AZA-TRICYCLO[6.3.1.0]DODECA-2,4,6-TRIENE TOSYLATE
69718-72-5
-
5-Ethyl-2-pyridineethanol Tosylate
144809-27-8
-
Edoxaban hydrochloride
480448-29-1
-
Phenyl tosylate Formula
640-60-8
-
2,3-Dihydrobenzofuran-5-ethanol Tosylate Formula
79679-49-5
-
Edoxaban Formula
480449-70-5
-
Niraparib tosylate Structure
1613220-15-7
-
S-Adenosyl-L-methionine tosylate Structure
71914-80-2
-
What is ARECAIDINE PROPARGYL ESTER TOSYLATE
147202-94-6
-
What is Bretylium tosylate
61-75-6